InvestorsHub Logo
Followers 12
Posts 616
Boards Moderated 0
Alias Born 05/06/2016

Re: buckysherm post# 1948

Saturday, 05/07/2016 10:27:54 PM

Saturday, May 07, 2016 10:27:54 PM

Post# of 232920
Bucky- I'm of the same mind set as you. The CEO said on the latest conference call that the recent trial results have impressed himself as well as the KOL. Pending FDA drug approval of PRO 140, this will eat in to Gileads market share of HIV medications which constitutes nearly half of their yearly revenue (IMO). I've been trying to play devils advocate as much as possible, but the data is there with PRO 140. I anticipate that the next few weeks will be very exciting.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News